Study to Evaluate the Effect of Different Warm-Up Times of Risankizumab Autoinjector (AI) on the Injection Pain Experiences in Healthy Volunteers
Clinical trial NCT05274087 · COMPLETED
Trial details
- NCT number
- NCT05274087
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-15
- Primary completion
- 2021-04-07
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.